179 related articles for article (PubMed ID: 19863491)
1. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride.
Mittal A; Parmar S; Singh B
Curr Drug Deliv; 2009 Oct; 6(5):511-9. PubMed ID: 19863491
[TBL] [Abstract][Full Text] [Related]
2. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
3. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization.
Aqil M; Zafar S; Ali A; Ahmad S
Curr Drug Deliv; 2005 Apr; 2(2):125-31. PubMed ID: 16305413
[TBL] [Abstract][Full Text] [Related]
4. Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer.
Aqil M; Bhavna ; Chowdhary I; Sultana Y; Talegaonkar S; Ahmad FJ; Ali MM
Curr Drug Deliv; 2008 Apr; 5(2):148-52. PubMed ID: 18393818
[TBL] [Abstract][Full Text] [Related]
5. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
[TBL] [Abstract][Full Text] [Related]
6. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
Aqil M; Ali A; Sultana Y; Najmi AK
Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
[TBL] [Abstract][Full Text] [Related]
7. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
8. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
Aggarwal G; Dhawan S; Harikumar SL
Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of a losartan transdermal system for the treatment of hypertension.
Shams MS; Alam MI; Ali A; Sultana Y; Aqil M
Drug Dev Ind Pharm; 2010 Apr; 36(4):385-92. PubMed ID: 20205600
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
[TBL] [Abstract][Full Text] [Related]
11. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of Transdermal Patches of Timolol Maleate.
Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
[TBL] [Abstract][Full Text] [Related]
14. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
15. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Kalita B; Das MK; Sarma M; Deka A
AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
[TBL] [Abstract][Full Text] [Related]
16. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
Gannu R; Vishnu YV; Kishan V; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
18. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
19. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
20. Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone.
Aggarwal G; Dhawan S; Hari Kumar SL
Drug Dev Ind Pharm; 2013 Jan; 39(1):39-50. PubMed ID: 22335586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
